RadNet, Inc.
Health
Performance
5.9
Risk
Sell
Buy
Curious about the Scores? Learn more.

RadNet, Inc. stock rating and score history

All changes in ratings, performance and outlook tracked over time.

08.02.2026
Signs of control returning. Still shaky, but not chaos.
31.01.2026
Fragile setup. Still failing to meet the key marks today.
14.01.2026
Still winning, but momentum’s cooling a bit.
20.08.2025
Pulse detected. Still fragile, but stabilizing.
RDNT
RadNet, Inc.
69.24
+7.32%
5.9
Sell
Buy
RadNet, Inc.

RadNet, Inc. stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does RadNet, Inc. do? Business model and key facts

Get the full picture of RadNet, Inc.: what it builds, where it operates, and how it makes money.

RadNet, Inc. Profile

Sector: Healthcare

Industry: Medical - Diagnostics & Research

Employees (FY): 11000

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems for the diagnostic imaging industry, including picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of images in the field of mammography, as well as AI solutions for lung and prostate cancer. As of December 31, 2021, it owned and managed 347 centers in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. The company was founded in 1981 and is headquartered in Los Angeles, California.

shop
Company facts
Howard G. Berger
CEO
11000
Employees worldwide
shop
Performance
11.05%
Last 12 months
262.89%
Last 5 years
shop
Growth
$1,83B
Revenue year
$38,84M
Net income
shop
Valuation
$5,36B
Market Cap
1826.32
Price/Earnings Ratio

Stocks related to RadNet, Inc.

Selected based on industry alignment and relative market positioning.

CRL
Charles River Laboratories International, Inc.
189.21
+3.00%
8.5
Sell
Buy
Charles River Laboratories International, Inc.
QGEN
Qiagen N.V.
50.95
-0.55%
3.9
Sell
Buy
Qiagen N.V.
ICLR
ICON Public Limited Company
150.59
+3.58%
7.0
Sell
Buy
ICON Public Limited Company
SHC
Sotera Health Company
17.75
+2.01%
6.4
Sell
Buy
Sotera Health Company
GRAL
GRAIL, Inc.
100.07
+6.39%
9.2
Sell
Buy
GRAIL, Inc.

RadNet, Inc. fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.